# Idhifa

NDC: 59572-710
Generic name: enasidenib mesylate
Labeler / Manufacturer: Celgene Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170801

FDA application: NDA209606

## Active ingredients

- ENASIDENIB MESYLATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59572-710"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59572-710
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6